GlaxoSmithKline PLC Director/PDMR Shareholding (1864N)
January 15 2019 - 11:15AM
UK Regulatory
TIDMGSK
RNS Number : 1864N
GlaxoSmithKline PLC
15 January 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Ms E N Walmsley
=== ======================== ===========================================
b) Position/status Chief Executive Officer
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 January 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.2875 1535.597
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-01-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr R G Connor
=== ======================== ===========================================
b) Position/status President, Global Vaccines
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 January 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.2875 42.320
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-01-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them ('PCA')
======================================================================
a) Name Mr S P Dingemans
=== ========================= ===========================================
b) Position/status Chief Financial Officer
=== ========================= ===========================================
c) Initial notification/ Initial notification
amendment
=== ========================= ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ========================= ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ========================= ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ========================= ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 January 2019.
=== ========================= ===========================================
c) Price(s) and volume(s) Price(s) Volume(s)
----------
GBP15.2875 1050.550
----------
=== ========================= ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ========================= ===========================================
e) Date of the 2019-01-11
transaction
=== ========================= ===========================================
f) Place of the transaction London Stock Exchange (XLON)
=== ========================= ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr J Ford
=== ======================== ===========================================
b) Position/status SVP & General Counsel
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 January 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.2875 0.012
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-01-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=========================================================================
a) Name Mr J Ford
=== ======================== ===============================================
b) Position/status SVP & General Counsel
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 10
January 2019.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$39.4400 75.536
----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2019-01-11
=== ======================== ===============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr N Hirons
=== ======================== ===========================================
b) Position/status SVP, Global Ethics & Compliance
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 January 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.2875 309.578
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-01-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=======================================================================
a) Name Mr N Hirons
=== ====================== ===============================================
b) Position/status SVP, Global Ethics & Compliance
=== ====================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ====================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =======================================================================
a) Name GlaxoSmithKline plc
=== ====================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =======================================================================
a) Description American Depositary Shares ('ADSs')
of the financial ISIN: US37733W1053
instrument
=== ====================== ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 10
January 2019
=== ====================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$39.4400 18.799
----------
=== ====================== ===============================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ===============================================
e) Date of the 2019-01-11
transaction
=== ====================== ===============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ====================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
========================================================================
a) Name Mr B McNamara
=== ======================= ===============================================
b) Position/status CEO, GSK Consumer Healthcare
=== ======================= ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================= ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================= ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================= ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description American Depositary Shares ('ADSs')
of the financial ISIN: US37733W1053
instrument
=== ======================= ===============================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 10
January 2019
=== ======================= ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
$39.4400 424.074
----------
=== ======================= ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================= ===============================================
e) Date of the 2019-01-11
transaction
=== ======================= ===============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ======================= ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr D Redfern
=== ======================== ===========================================
b) Position/status Chief Strategy Officer
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 January 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.2875 1945.478
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-01-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr R Simard
=== ======================== ===========================================
b) Position/status President, Pharma Supply Chain
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 January 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.2875 363.181
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-01-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Ms C Thomas
=== ======================== ===========================================
b) Position/status SVP, Human Resources
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 10 January 2019.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.2875 357.061
----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-01-11
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
============================================================================
a) Name Mr P C Thomson
=== ====================== ====================================================
b) Position/status President, Global Affairs
=== ====================== ====================================================
c) Initial notification/ Initial notification
amendment
=== ====================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ============================================================================
a) Name GlaxoSmithKline plc
=== ====================== ====================================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ============================================================================
a) Description Ordinary shares of 25 pence each ('Ordinary
of the financial Shares')
instrument ISIN: GB0009252882
=== ====================== ====================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to shareholders
on 10 January 2019.
=== ====================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.2875 210.297
----------
=== ====================== ====================================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ====================================================
e) Date of the 2019-01-11
transaction
=== ====================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
============================================================================
a) Name Mrs K Thomson
=== ====================== ====================================================
b) Position/status PCA of Mr P C Thomson (President, Global
Affairs)
=== ====================== ====================================================
c) Initial notification/ Initial notification
amendment
=== ====================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ============================================================================
a) Name GlaxoSmithKline plc
=== ====================== ====================================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ============================================================================
a) Description Ordinary shares of 25 pence each ('Ordinary
of the financial Shares')
instrument ISIN: GB0009252882
=== ====================== ====================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to shareholders
on 10 January 2019.
=== ====================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.2875 127.445
----------
=== ====================== ====================================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ====================================================
e) Date of the 2019-01-11
transaction
=== ====================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ====================== ====================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDELFFKFFFBBX
(END) Dow Jones Newswires
January 15, 2019 12:15 ET (17:15 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024